Provided by Tiger Fintech (Singapore) Pte. Ltd.

GENSCRIPT BIO

12.840
+0.1401.10%
Volume:14.41M
Turnover:185.33M
Market Cap:27.57B
PE:-36.50
High:13.060
Open:12.900
Low:12.660
Close:12.700
Loading ...

Genscript Biotech Expects Higher 2024 Net Profit

MT Newswires Live
·
17 Feb

Retail investors are Genscript Biotech Corporation's (HKG:1548) biggest owners and were rewarded after market cap rose by HK$1.8b last week

Simply Wall St.
·
13 Feb

Investors Still Aren't Entirely Convinced By Genscript Biotech Corporation's (HKG:1548) Revenues Despite 27% Price Jump

Simply Wall St.
·
13 Feb

Genscript Biotech's Associate Logs $334 Million in Carvykti Drug Sales in Q4

MT Newswires Live
·
23 Jan

BUZZ-GenScript jumps on associate's cancer drug's $334 mln sales

Reuters
·
23 Jan

Genscript Biotech Corporation (HKG:1548) Shares Could Be 49% Below Their Intrinsic Value Estimate

Simply Wall St.
·
21 Jan

U.S. RESEARCH ROUNDUP-Hershey, Paychex, Revvity

Reuters
·
23 Dec 2024

FDA Grants Ind Approval to Base Therapeutics' Base-Edited Nk Cell Therapy, Powered by Genscript's Cgmp Sgrna and Cytoselect Platform

THOMSON REUTERS
·
10 Dec 2024

Genscript Biotech (HKG:1548) adds HK$983m to market cap in the past 7 days, though investors from three years ago are still down 72%

Simply Wall St.
·
07 Dec 2024

Genscript Biotech's Rotating CEO Steps Down

MT Newswires Live
·
02 Dec 2024

BRIEF-Genscript Biotech Says Liu Zhenyu Tendered Resignation As Rotating CEO

Reuters
·
02 Dec 2024

Genscript Biotech - Liu Zhenyu Tendered Resignation as Rotating CEO

THOMSON REUTERS
·
02 Dec 2024

Market Still Lacking Some Conviction On Genscript Biotech Corporation (HKG:1548)

Simply Wall St.
·
19 Nov 2024

Genscript Biotech Enters Sub-License Contract for Anti-PD-1 Single Domain Antibodies

MT Newswires Live
·
15 Nov 2024

BRIEF-Genscript Biotech Says Probio Nanjing Agrees To Grant To Lanova An Exclusive License For Anti-Pd-1 Single Domain Antibodies

Reuters
·
15 Nov 2024

Genscript Biotech - Probio Nanjing Agrees to Grant to Lanova an Exclusive License for Anti-Pd-1 Single Domain Antibodies

THOMSON REUTERS
·
15 Nov 2024